Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

ClinicalTrials.gov ID: NCT00619801

Public ClinicalTrials.gov record NCT00619801. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double Blind, Placebo Controlled Parallel Group Study of the Safety of Levocetirizine Dihydrochloride Oral Liquid Formulation b.i.d Dosing in Children Aged 1 to < 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown Origin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the safety of the oral formulation of levocetirizine in children ages 1 to less than 6 years old who suffer from allergic rhinitis or chronic urticaria of unknown origin.

Study identification

NCT ID
NCT00619801
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
UCB Pharma
Industry
Enrollment
173 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years to 6 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2008 (Type not available)
Primary completion
Jul 2008 (Actual)
Completion
Jul 2008 (Actual)
Last update posted
Mar 6, 2015

2008

United States locations

U.S. sites
28
U.S. states
16
U.S. cities
28
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Little Rock Arkansas — —
Not listed Beverly Hills California — —
Not listed Crescent City California — —
Not listed Huntington Beach California — —
Not listed Mission Viejo California — —
Not listed San Diego California — —
Not listed Wildomar California — —
Not listed Denver Colorado — —
Not listed Pueblo Colorado — —
Not listed Savannah Georgia — —
Not listed Stockbridge Georgia — —
Not listed Normal Illinois — —
Not listed Overlook Park Kansas — —
Not listed Owensboro Kentucky — —
Not listed Metarie Louisiana — —
Not listed Baltimore Maryland — —
Not listed Omaha Nebraska — —
Not listed Papillon Nebraska — —
Not listed Oklahoma City Oklahoma — —
Not listed Medford Oregon — —
Not listed Portland Oregon — —
Not listed Barnwell South Carolina — —
Not listed Charleston South Carolina — —
Not listed Dallas Texas — —
Not listed El Paso Texas — —
Not listed New Braunfels Texas — —
Not listed Richmond Virginia — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00619801, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 6, 2015 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00619801 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →